Such a saturation of the enzyme pool by increased amounts of lipoperoxides results in its decreased activity [56], and this loss in PON1 activity is indeed observed in the course of oxidative stress-related diseases, such as cardiovascular diseases (CVD), diabetes, liver diseases, cancer, immune diseases or some neurological disorders. The gene discussed is PON1; the disease is diabetes mellitus.